Michael D. Blaszyk, Director at ImmunityBio, Inc. (IBRX), bought 95,345 shares at $2.77 ($262K) on 2023-06-05, disclosed to the SEC on 2023-06-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.72 | 23,430 | $64K | 24.3% |
| 2 | $2.72 | 23,430 | $64K | 24.3% |
| 3 | $2.75 | 485 | $1K | 0.5% |
| 4 | $2.77 | 48,000 | $133K | 50.8% |
| Total | $2.75 avg | 95,345 | $262K | 100% |